Amundi

Amundi’s Myriad Genetics MYGN Stock Holding History

Amundi’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$126K	Buy	27,976 +12,367	+79%	+$64.4K	﹤0.01%	1945
2025 Q4	$96K	Buy	15,609 +842	+6%	+$6.11K	﹤0.01%	1813
2025 Q3	$118K	Sell	14,767 -98,428	-87%	-$584K	﹤0.01%	1579
2025 Q2	$637K	Buy	113,195 +76,330	+207%	+$451K	﹤0.01%	1315
2025 Q1	$310K	Sell	36,865 -7,113	-16%	-$85.4K	﹤0.01%	1593
2024 Q4	$650K	Buy	43,978 +27,989	+175%	+$516K	﹤0.01%	1506
2024 Q3	$415K	Buy	15,989 +1,892	+13%	+$51.2K	﹤0.01%	1477
2024 Q2	$352K	Sell	14,097 -6,265	-31%	-$137K	﹤0.01%	1426
2024 Q1	$377K	Buy	20,362 +3,934	+24%	+$84.6K	﹤0.01%	1483
2023 Q4	$297K	Buy	16,428 +5,985	+57%	+$104K	﹤0.01%	1538
2023 Q3	$152K	Sell	10,443 -15	-0.1%	-$285	﹤0.01%	1664
2023 Q2	$243K	Sell	10,458 -940	-8%	-$20.5K	﹤0.01%	1556
2023 Q1	$265K	Buy	+11,398	New	+$231K	﹤0.01%	1497
2021 Q3	–	Sell	-136,000	Closed	-$4.16M	–	1609
2021 Q2	$4.16M	Buy	+136,000	New	+$3.93M	﹤0.01%	1042

Other funds holding MYGN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return